Abstract

Importance  State cannabis laws are changing rapidly. Research is inconclusive about their association with rates of self-harm and assault. Existing studies have not considered variations in cannabis commercialization across states over time.

Objective  To evaluate the association of state medical and recreational cannabis laws with self-harm and assault, overall and by age and sex, while considering varying degrees of commercialization.

Design, Setting, and Participants  Using a cohort design with panel fixed-effects analysis, within-state changes in claims for self-harm and...

"Reviews of preclinical research and clinical safety and efficacy of cannabis and cannabinoids for pain relief have identified important research gaps. Due to the lack of high-quality clinical evidence, the International Association for the Study of Pain (IASP) does not currently endorse current use of cannabis and cannabinoids for pain relief. International Association for the Study of Pain recognises the pressing need for preclinical and clinical studies to fill the research gap, and for education on this topic."

IASP Presidential Task Force on Cannabis and Cannabinoid Analgesia